Satsuma Pharmaceuticals, Inc. announced that Immediately following the Effective Time Tom O'Neil ceased serving as Chief Financial Officer of the Company.
Satsuma Pharmaceuticals, Inc.
Equities
STSA
US80405P1075
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
-3.23% | 102B | |
+1.50% | 96.29B | |
+2.13% | 22.18B | |
-15.50% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-15.56% | 16.36B | |
+5.14% | 13.97B | |
+33.55% | 12.17B |